We are live on ! Find out more

2,717 hedge funds and large institutions have $118B invested in Amgen in 2023 Q4 according to their latest regulatory filings, with 161 funds opening new positions, 982 increasing their positions, 1,055 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 161 | Existing positions closed: 90

34% more capital inflows, than outflows

Capital inflows: $5.72B | Capital outflows: $4.26B

9% more funds holding

Funds holding: 2,499 → 2,717 (+218)

0.88% more ownership

Funds ownership: 75.84% → 76.72% (+0.88%)

6% less call options, than puts

Call options by funds: $1.91B | Put options by funds: $2.03B

7% less repeat investments, than reductions

Existing positions increased: 982 | Existing positions reduced: 1,055

10% less funds holding in top 10

Funds holding in top 10: 87 → 78 (-9)

Holders
2,717
Holders Change
+218
Holders Change %
+8.72%
% of All Funds
39.51%
Holding in Top 10
78
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-10.34%
% of All Funds
1.13%
New
161
Increased
982
Reduced
1,055
Closed
90
Calls
$1.91​B
Puts
$2.03​B
Net Calls
-⁠$117​M
Net Calls Change
-⁠$84.7​M

AMGN Hedge Fund Activity: Q4 2023 in Review

2,717 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2023, worth a combined $118B — up 8.4% from $109B a quarter earlier.

Buyers outnumbered sellers: 161 funds opened new AMGN positions and 90 closed out — a net gain of 71 holders — while 982 added to existing stakes and 1,055 trimmed.

The largest buyer was Barclays, adding an estimated $378M. The largest seller was Capital Research Global Investors, cutting an estimated $487M.

  • 2,717 institutional investors held Amgen (AMGN) as of Q4 2023, up from 2,499 in Q3 2023.
  • Funds reported $118B of Amgen stock for Q4 2023, up 8.4% quarter-over-quarter.
  • 161 funds opened new Amgen positions in Q4 2023 and 90 closed out, a net change of +71 holders.
  • The largest Amgen buyer in Q4 2023 was Barclays, an estimated $378M added.
  • The largest Amgen seller in Q4 2023 was Capital Research Global Investors, an estimated $487M sold.

Based on aggregated 13F filings for Q4 2023.